Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Bristol Myers Squibb)"
Count: 2468
Selected: 0
| NCT ID | Title |
|---|
| NCT05498480 | Study of Relatlimab in Combination With Nivolumab in Chinese Participants | ||
| NCT05496192 | A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer | ||
| NCT05489705 | A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) | ||
| NCT05478499 | Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis | ||
| NCT05470985 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy | ||
| NCT05469737 | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) | ||
| NCT05445440 | A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine | ||
| NCT05432622 | A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy | ||
| NCT05426239 | Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database | ||
| NCT05421442 | A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database | ||
| NCT05421299 | A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate | ||
| NCT05420909 | A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC) | ||
| NCT05414175 | A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy | ||
| NCT05413044 | A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register | ||
| NCT05413018 | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission | ||
| NCT05409157 | A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants | ||
| NCT05407675 | A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors | ||
| NCT05405543 | A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants | ||
| NCT05389722 | A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants | ||
| NCT05382715 | A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis | ||
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05369832 | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice | ||
| NCT05362045 | A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants | ||
| NCT05350800 | A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants | ||
| NCT05337345 | A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants | ||
| NCT05337137 | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer | ||
| NCT05335031 | A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®) | ||
| NCT05334719 | A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer | ||
| NCT05328908 | A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer | ||
| NCT05324436 | A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) | ||
| NCT05320094 | A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants | ||
| NCT05304533 | A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants | ||
| NCT05303220 | A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants | ||
| NCT05301972 | Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor | ||
| NCT05298592 | A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors | ||
| NCT05297565 | A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection | ||
| NCT05284890 | A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants | ||
| NCT05255601 | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma | ||
| NCT05250817 | A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer | ||
| NCT05244070 | A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT05236738 | A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions | ||
| NCT05232643 | A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation | ||
| NCT05218902 | A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML) | ||
| NCT05217082 | A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure | ||
| NCT05210894 | Expanded Access for Anti-IL8 | ||
| NCT05209295 | A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Participants | ||
| NCT05197426 | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission | ||
| NCT05187286 | Expanded Access for Apixaban | ||
| NCT05170685 | Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab | ||
| NCT05170672 | Expanded Access for Abatacept |
